The Biden Administration is indeed showing interest in expanding coverage for obesity treatments under Medicare and Medicaid. The plan is to provide better access to anti-obesity drugs and other interventions due to the rising health crisis associated with obesity. However, whether specific brands like Ozempic and Wegovy will be covered is not explicitly mentioned.
Medicare and Medicaid coverage can be complex because it’s subject to numerous conditions and restrictions, and can vary by individual state. Therefore, it’s advised to contact Medicare or Medicaid directly or consult a healthcare provider for the most accurate and personalized information.
As of now, some Medicare Part D prescription drug plans may cover the cost of these drugs. However, it’s important to note that you may still be responsible for part of the cost in the form of a copayment, coinsurance, or deductible.
Remember, health insurance policies often change, especially with a new administration in the White House. So, it’s always a good idea to stay updated on those changes.
